Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial.

Bjerre ED, Petersen TH, Jørgensen AB, Johansen C, Krustrup P, Langdahl B, Poulsen MH, Madsen SS, Østergren PB, Borre M, Rørth M, Brasso K, Midtgaard J.

PLoS Med. 2019 Oct 1;16(10):e1002936. doi: 10.1371/journal.pmed.1002936. eCollection 2019 Oct.

2.

Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells.

Laursen EB, Fredsøe J, Schmidt L, Strand S, Kristensen H, Ildor Rasmussen AK, Daugaard TF, Mouritzen P, Høyer S, Kristensen G, Stroomberg HV, Brasso K, Røder MA, Borre M, Sørensen KD.

Am J Pathol. 2019 Sep 17. pii: S0002-9440(19)30711-4. doi: 10.1016/j.ajpath.2019.08.007. [Epub ahead of print]

3.

Risk of Depression After Radical Prostatectomy-A Nationwide Registry-based Study.

Friberg AS, Dalton SO, Larsen SB, Andersen EW, Krøyer A, Helgstrand JT, Røder MA, Johansen C, Brasso K.

Eur Urol Oncol. 2019 Jul 22. pii: S2588-9311(19)30101-4. doi: 10.1016/j.euo.2019.06.020. [Epub ahead of print]

PMID:
31345731
4.

Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis.

Kristensen G, Berg KD, Toft BG, Stroomberg HV, Nolley R, Brooks JD, Brasso K, Roder MA.

J Clin Pathol. 2019 Oct;72(10):696-704. doi: 10.1136/jclinpath-2019-205940. Epub 2019 Jul 22.

PMID:
31331953
5.

Prognostic implication of gait function following treatment for spinal cord compression in men diagnosed with prostate cancer.

Lehrmann-Lerche CS, Thomsen FB, Røder MA, Suppli MH, Brasso K, Berg KD.

Scand J Urol. 2019 Jun 17:1-7. doi: 10.1080/21681805.2019.1626478. [Epub ahead of print]

PMID:
31204549
6.

Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.

Thomsen FB, Røder MA, Jakobsen H, Langkilde NC, Borre M, Jakobsen EB, Frey A, Lund L, Lunden D, Dahl C, Brasso K.

Clin Genitourin Cancer. 2019 Aug;17(4):e814-e821. doi: 10.1016/j.clgc.2019.05.005. Epub 2019 May 21.

PMID:
31196798
7.

Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men.

Moustsen IR, Larsen SB, Duun-Henriksen AK, Tjønneland A, Kjær SK, Brasso K, Johansen C, Dalton SO.

Br J Cancer. 2019 May;120(11):1067-1074. doi: 10.1038/s41416-019-0468-8. Epub 2019 May 8.

PMID:
31065112
8.

Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series.

Malling B, Røder MA, Lindh M, Frevert S, Brasso K, Lönn L.

Cardiovasc Intervent Radiol. 2019 Oct;42(10):1405-1412. doi: 10.1007/s00270-019-02227-4. Epub 2019 May 6.

PMID:
31062066
9.

Prostate Artery Embolization for Lower Urinary Tract Symptoms in Men Unfit for Surgery.

Malling B, Lönn L, Jensen RJ, Lindh M, Frevert S, Brasso K, Røder MA.

Diagnostics (Basel). 2019 Apr 25;9(2). pii: E46. doi: 10.3390/diagnostics9020046.

10.

Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden.

Kjærulff TM, Ersbøll AK, Green A, Emneus M, Brasso K, Iversen P, Pukkala E, Bolin K, Thygesen LC.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):980-986. doi: 10.1158/1055-9965.EPI-18-0904. Epub 2019 Mar 6.

PMID:
30842126
11.

Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.

Skriver C, Dehlendorff C, Borre M, Brasso K, Larsen SB, Dalton SO, Nørgaard M, Pottegård A, Hallas J, Sørensen HT, Friis S.

Ann Intern Med. 2019 Apr 2;170(7):443-452. doi: 10.7326/M17-3085. Epub 2019 Mar 5.

PMID:
30831581
12.

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors.

Kristensen G, Strand SH, Røder MA, Berg KD, Toft BG, Høyer S, Borre M, Sørensen KD, Brasso K.

Int J Mol Sci. 2019 Feb 27;20(5). pii: E1025. doi: 10.3390/ijms20051025.

13.

The association between education and risk of major cardiovascular events among prostate cancer patients: a study from the Diet, Cancer and Health study.

Moustsen IR, Friberg AS, Larsen SB, Duun-Henriksen AK, Tjønneland A, Kjaer SK, Brasso K, Johansen C, Dalton SO.

Acta Oncol. 2019 May;58(5):715-721. doi: 10.1080/0284186X.2019.1572924. Epub 2019 Feb 13.

PMID:
30757932
14.

Educational level and the risk of depression after prostate cancer.

Friberg AS, Rask Moustsen I, Benzon Larsen S, Hartung T, Wreford Andersen E, Halgren Olsen M, Tjønneland A, Kjaer SK, Johansen C, Brasso K, Oksbjerg Dalton S.

Acta Oncol. 2019 May;58(5):722-729. doi: 10.1080/0284186X.2019.1566773. Epub 2019 Jan 30.

PMID:
30700197
15.

The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis.

Jønck S, Helgstrand JT, Røder MA, Klemann N, Grønkaer Toft B, Brasso K.

Scand J Urol. 2018 Oct - Dec;52(5-6):358-363. doi: 10.1080/21681805.2018.1534885. Epub 2019 Jan 9.

PMID:
30624125
16.

SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.

Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O.

Scand J Urol. 2018 Oct - Dec;52(5-6):313-320. doi: 10.1080/21681805.2018.1520295. Epub 2018 Dec 26.

PMID:
30585526
17.

Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial.

Bjerre ED, Brasso K, Jørgensen AB, Petersen TH, Eriksen AR, Tolver A, Christensen JF, Poulsen MH, Madsen SS, Østergren PB, Borre M, Krustrup P, Johansen C, Rørth M, Midtgaard J.

Sports Med. 2019 Jan;49(1):145-158. doi: 10.1007/s40279-018-1031-0.

18.

Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer.

Flores-Morales A, Bergmann TB, Lavallee C, Batth TS, Lin D, Lerdrup M, Friis S, Bartels A, Kristensen G, Krzyzanowska A, Xue H, Fazli L, Hansen KH, Røder MA, Brasso K, Moreira JM, Bjartell A, Wang Y, Olsen JV, Collins CC, Iglesias-Gato D.

Clin Cancer Res. 2019 Jan 15;25(2):595-608. doi: 10.1158/1078-0432.CCR-18-0729. Epub 2018 Oct 1.

PMID:
30274982
19.

Active Surveillance for Localized Prostate Cancer: Nationwide Observational Study.

Thomsen FB, Jakobsen H, Langkilde NC, Borre M, Jakobsen EB, Frey A, Lund L, Lunden D, Dahl C, Helgstrand JT, Brasso K.

J Urol. 2019 Mar;201(3):520-527. doi: 10.1016/j.juro.2018.09.045.

PMID:
30240689
20.

Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer.

Kristensen G, Røder MA, Berg KD, Elversang J, Iglesias-Gato D, Moreira J, Toft BG, Brasso K.

APMIS. 2018 Oct;126(10):804-813. doi: 10.1111/apm.12886. Epub 2018 Sep 6.

PMID:
30191621
21.

[Prostate artery embolisation is a new treatment for prostate disease].

Malling B, Lönn LB, Frevert S, Lindh M, Bagi P, Vejborg I, Brasso K, Røder MA.

Ugeskr Laeger. 2018 Aug 13;180(33). pii: V01180004. Danish.

PMID:
30084348
22.

Football training over 5 years is associated with preserved femoral bone mineral density in men with prostate cancer.

Uth J, Fristrup B, Haahr RD, Brasso K, Helge JW, Rørth M, Midtgaard J, Helge EW, Krustrup P.

Scand J Med Sci Sports. 2018 Aug;28 Suppl 1:61-73. doi: 10.1111/sms.13242. Epub 2018 Jul 12.

PMID:
30001572
23.

Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis.

Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L.

Eur Radiol. 2019 Jan;29(1):287-298. doi: 10.1007/s00330-018-5564-2. Epub 2018 Jun 14.

PMID:
29948079
24.

The "Football is Medicine" platform-scientific evidence, large-scale implementation of evidence-based concepts and future perspectives.

Krustrup P, Williams CA, Mohr M, Hansen PR, Helge EW, Elbe AM, de Sousa M, Dvorak J, Junge A, Hammami A, Holtermann A, Larsen MN, Kirkendall D, Schmidt JF, Andersen TR, Buono P, Rørth M, Parnell D, Ottesen L, Bennike S, Nielsen JJ, Mendham AE, Zar A, Uth J, Hornstrup T, Brasso K, Nybo L, Krustrup BR, Meyer T, Aagaard P, Andersen JL, Hubball H, Reddy PA, Ryom K, Lobelo F, Barene S, Helge JW, Fatouros IG, Nassis GP, Xu JC, Pettersen SA, Calbet JA, Seabra A, Rebelo AN, Figueiredo P, Póvoas S, Castagna C, Milanovic Z, Bangsbo J, Randers MB, Brito J.

Scand J Med Sci Sports. 2018 Aug;28 Suppl 1:3-7. doi: 10.1111/sms.13220. Epub 2018 Jun 19. No abstract available.

PMID:
29917263
25.

Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.

Helgstrand JT, Røder MA, Klemann N, Toft BG, Lichtensztajn DY, Brooks JD, Brasso K, Vainer B, Iversen P.

Cancer. 2018 Jul 15;124(14):2931-2938. doi: 10.1002/cncr.31384. Epub 2018 May 3.

26.

The use of transrectal ultrasound-guided biopsy following the introduction of prostate-specific antigen testing in Denmark: a population-based analysis.

Klemann N, Røder MA, Helgstrand JT, Brasso K, Toft BG, Vainer B, Iversen P.

Scand J Urol. 2018 Jun;52(3):169-173. doi: 10.1080/21681805.2018.1444672. Epub 2018 Mar 8.

PMID:
29514539
27.

Reply to M. Nayan et al.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.

J Clin Oncol. 2018 Feb 20;36(6):629-630. doi: 10.1200/JCO.2017.76.7186. Epub 2017 Dec 20. No abstract available.

PMID:
29261443
28.

Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.

Meijer M, Thygesen LC, Green A, Emneus M, Brasso K, Iversen P, Pukkala E, Bolin K, Stavem K, Ersbøll AK.

Cancer Med. 2018 Jan;7(1):254-260. doi: 10.1002/cam4.1273. Epub 2017 Dec 13.

29.

Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States.

Loft MD, Berg KD, Kjaer A, Iversen P, Ferrari M, Zhang CA, Brasso K, Brooks JD, Røder MA.

Clin Genitourin Cancer. 2017 Sep 6. pii: S1558-7673(17)30269-0. doi: 10.1016/j.clgc.2017.08.014. [Epub ahead of print]

PMID:
28988695
30.

Active surveillance for localized prostate cancer: update of a prospective single-center cohort.

Thostrup M, Thomsen FB, Iversen P, Brasso K.

Scand J Urol. 2018 Feb;52(1):14-19. doi: 10.1080/21681805.2017.1380697. Epub 2017 Sep 28.

PMID:
28958194
31.

Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.

Mikkelsen MK, Thomsen FB, Berg KD, Jarden M, Larsen SB, Hansen RB, Brasso K.

Scand J Urol. 2017 Dec;51(6):464-469. doi: 10.1080/21681805.2017.1362032. Epub 2017 Aug 23.

PMID:
28831860
32.

Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.

Becker JA, Berg KD, Røder MA, Brasso K, Iversen P.

Scand J Urol. 2018 Feb;52(1):1-7. doi: 10.1080/21681805.2017.1363816. Epub 2017 Aug 18. Review.

PMID:
28818014
33.

Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.

J Clin Oncol. 2017 Oct 10;35(29):3290-3297. doi: 10.1200/JCO.2016.71.8981. Epub 2017 Aug 14.

PMID:
28806117
34.

Diagnostic characteristics of lethal prostate cancer.

Helgstrand JT, Røder MA, Klemann N, Toft BG, Brasso K, Vainer B, Iversen P.

Eur J Cancer. 2017 Oct;84:18-26. doi: 10.1016/j.ejca.2017.07.007. Epub 2017 Aug 2.

PMID:
28779631
35.

The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy.

Kurbegovic S, Berg KD, Thomsen FB, Gruschy L, Iversen P, Brasso K, Røder MA.

Scand J Urol. 2017 Dec;51(6):450-456. doi: 10.1080/21681805.2017.1356369. Epub 2017 Aug 1.

PMID:
28762283
36.

Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.

Steuber T, Berg KD, Røder MA, Brasso K, Iversen P, Huland H, Tiebel A, Schlomm T, Haese A, Salomon G, Budäus L, Tilki D, Heinzer H, Graefen M, Mandel P.

Eur Urol Focus. 2017 Dec;3(6):646-649. doi: 10.1016/j.euf.2017.06.016. Epub 2017 Jul 8.

PMID:
28753877
37.

The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.

Røder MA, Berg KD, Loft MD, Thomsen FB, Ferrari M, Kurbegovic S, Rytgaard HC, Gruschy L, Brasso K, Gerds TA, Kjær A, Brooks JD, Iversen P.

Eur Urol Focus. 2018 Apr;4(3):360-368. doi: 10.1016/j.euf.2016.11.014. Epub 2016 Dec 9.

PMID:
28753827
38.

Isolated testicular prostate cancer metastasis.

Maibom SL, Jacobsen A, Hansen RB, Brasso K.

Scand J Urol. 2017 Oct;51(5):426-427. doi: 10.1080/21681805.2017.1347818. Epub 2017 Jul 26. No abstract available.

PMID:
28743224
39.

Plasma levels of intact and cleaved urokinase plasminogen activator receptor (uPAR) in men with clinically localised prostate cancer.

Kristensen G, Berg KD, Lippert S, Christensen IJ, Brasso K, Høyer-Hansen G, Røder MA.

J Clin Pathol. 2017 Dec;70(12):1063-1068. doi: 10.1136/jclinpath-2017-204475. Epub 2017 Jun 12.

PMID:
28607123
40.

Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.

Heering M, Berg KD, Brasso K, Iversen P, Røder MA.

Surg Oncol. 2017 Mar;26(1):21-27. doi: 10.1016/j.suronc.2016.12.002. Epub 2016 Dec 8.

PMID:
28317581
41.

Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study.

Klemann N, Røder MA, Helgstrand JT, Brasso K, Toft BG, Vainer B, Iversen P.

Lancet Oncol. 2017 Feb;18(2):221-229. doi: 10.1016/S1470-2045(17)30025-6. Epub 2017 Jan 14.

PMID:
28094199
42.

Improved survival for patients with de novo metastatic prostate cancer in the last 20 years.

Berg KD, Thomsen FB, Mikkelsen MK, Ingimarsdóttir IJ, Hansen RB, Kejs AM, Brasso K.

Eur J Cancer. 2017 Feb;72:20-27. doi: 10.1016/j.ejca.2016.11.025. Epub 2016 Dec 23.

PMID:
28024263
43.

Antibiotic prophylaxis and complications following prostate biopsies - a systematic review.

Klemann N, Helgstrand JT, Brasso K, Vainer B, Iversen P, Røder MA.

Dan Med J. 2017 Jan;64(1). pii: A5323. Review.

PMID:
28007054
44.

Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors.

Larsen SB, Brasso K, Christensen J, Johansen C, Tjønneland A, Friis S, Iversen P, Dalton SO.

Acta Oncol. 2017 Apr;56(4):563-568. doi: 10.1080/0284186X.2016.1260771. Epub 2016 Dec 2.

PMID:
27911129
45.

The Danish Prostate Cancer Database.

Nguyen-Nielsen M, Høyer S, Friis S, Hansen S, Brasso K, Jakobsen EB, Moe M, Larsson H, Søgaard M, Nakano A, Borre M.

Clin Epidemiol. 2016 Oct 25;8:649-653. eCollection 2016. Review.

46.

Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.

Thomsen FB, Folkvaljon Y, Brasso K, Loeb S, Robinson D, Egevad L, Stattin P.

J Surg Oncol. 2016 Nov;114(6):664-670. doi: 10.1002/jso.24408. Epub 2016 Aug 11.

47.

Danish Prostate Cancer Registry - methodology and early results from a novel national database.

Helgstrand JT, Klemann N, Røder MA, Toft BG, Brasso K, Vainer B, Iversen P.

Clin Epidemiol. 2016 Sep 27;8:351-360. eCollection 2016.

48.
49.

Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging.

Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A.

J Nucl Med. 2017 Mar;58(3):379-386. doi: 10.2967/jnumed.116.178970. Epub 2016 Sep 8.

50.

Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.

Skriver C, Dehlendorff C, Borre M, Brasso K, Sørensen HT, Hallas J, Larsen SB, Tjønneland A, Friis S.

Cancer Causes Control. 2016 Sep;27(9):1067-79. doi: 10.1007/s10552-016-0785-7. Epub 2016 Aug 9.

PMID:
27503490

Supplemental Content

Loading ...
Support Center